<DOC>
	<DOCNO>NCT01965301</DOCNO>
	<brief_summary>Phase I Single Ascending Dose ( Part 1 ) , phase IIa Proof Of Concept ( Part 2 )</brief_summary>
	<brief_title>First-time-in-man , Assess Safety , Tolerability , Pharmacokinetics Pharmacodynamics BP1.5375</brief_title>
	<detailed_description>This single center , Double-blind , placebo control , randomize study ass safety , tolerability , pharmacokinetics pharmacodynamics BP1.5375 single oral administration range healthy male subject ( Part 1 ) follow assessment effect 3 single different BP1.5375 oral dos polysomnography comparison 50 mg diphenhydramine placebo healthy male subject ( Part 2 ) .</detailed_description>
	<mesh_term>Diphenhydramine</mesh_term>
	<mesh_term>Promethazine</mesh_term>
	<criteria>Signed informed consent prior studymandated procedure . Healthy male subject age 18 45 year ( inclusive ) . Subjects body weight least 50 kg body mass index ( BMI ) 18.0 28.0 kg/m2 ( inclusive ) . Healthy subject , base history , physical examination , complete laboratory evaluation , 12lead ECG . Normal arterial blood pressure ( BP ) pulse rate , abnormal , consider clinically significant investigator . Normal BP [ 100140 ] mmHg systolic [ 4590 ] mmHg diastolic . Normal pulse rate [ 4090 ] bpm 5 minute rest lie position . Ability communicate well investigator local language , understand comply requirement study . Subject history cardiovascular , pulmonary , gastrointestinal , hepatic , renal , metabolic , haematological , neurological , psychiatric , systemic , infectious disease , condition , opinion investigator , would jeopardize safety subject , impact validity study result . Previous history fainting , collapse , syncope , orthostatic hypotension , vasovagal reaction . Haematology , clinical chemistry , urinalysis result deviate normal range clinically relevant extent screening . Clinically significant finding physical examination screening . 12lead electrocardiogram ( ECG ) clinically relevant abnormality supine position screening . Positive result urine drug screen screen . Veins unsuitable i.v . puncture either arm ( e.g. , vein difficult locate , access puncture , vein tendency rupture puncture ) . Treatment prescribed medication ( include vaccine ) overthecounter ( OTC ) medication ( include herbal medicine St John 's Wort ) within 2 week prior ( first ) schedule administration study drug , except paracetamol ( maximum 1 g/day ) . Treatment another investigational drug within 3 month prior screen participate four investigational drug study within 1 year prior screen . History clinical evidence alcoholism drug abuse within 3year period prior screen . History clinical evidence disease , and/or existence surgical medical condition , might interfere absorption , distribution , metabolism excretion study drug . Have undergone surgery donate amount equal 500 mL blood , 300 mL plasma , within 3 month prior screen . Positive result hepatitis serology test ( HBsAg , antiHCV ) , screen . Positive result HIV 1 or/and 2 serology screening . History allergy diphenhydramine antihistaminic drug . Smoking 5 cigarette per day .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>